Silymarin, vitamin C, vitamin E, and coenzyme Q10 and selenomethionine (Medronys epato®) contain a capsule twice a day for 45- and 90-days treatments that has histologically improved liver function and reduced the marker enzymes of liver toxicity (ALT, AST, ALP, and GGT) and lipid markers (total cholesterol, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and TG) in serum of NAFLD patients (Curcio et al., [112]). Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.